234 related articles for article (PubMed ID: 33398063)
21. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
22. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Eiro N; Cid S; Aguado N; Fraile M; de Pablo N; Fernández B; Domínguez F; González LO; Vizoso FJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396463
[TBL] [Abstract][Full Text] [Related]
23. SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.
Alcaraz LB; Mallavialle A; Mollevi C; Boissière-Michot F; Mansouri H; Simony-Lafontaine J; Laurent-Matha V; Chardès T; Jacot W; Turtoi A; Roger P; Guiu S; Liaudet-Coopman E
Int J Cancer; 2023 Mar; 152(6):1243-1258. PubMed ID: 36346290
[TBL] [Abstract][Full Text] [Related]
24. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
[TBL] [Abstract][Full Text] [Related]
25. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
26. Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer.
Lawal B; Wu AT; Chen CH; T A G; Wu SY
Biomed Pharmacother; 2023 Jul; 163():114800. PubMed ID: 37141739
[TBL] [Abstract][Full Text] [Related]
27. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
28. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
[TBL] [Abstract][Full Text] [Related]
29. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
[TBL] [Abstract][Full Text] [Related]
30. FGF13 promotes metastasis of triple-negative breast cancer.
Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
[TBL] [Abstract][Full Text] [Related]
31. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
Legrier ME; Bièche I; Gaston J; Beurdeley A; Yvonnet V; Déas O; Thuleau A; Château-Joubert S; Servely JL; Vacher S; Lassalle M; Depil S; Tucker GC; Fontaine JJ; Poupon MF; Roman-Roman S; Judde JG; Decaudin D; Cairo S; Marangoni E
Br J Cancer; 2016 Jan; 114(2):177-87. PubMed ID: 26695443
[TBL] [Abstract][Full Text] [Related]
32. Cancer‑associated fibroblast‑derived LRRC15 promotes the migration and invasion of triple‑negative breast cancer cells via Wnt/β‑catenin signalling pathway regulation.
Yang Y; Wu H; Fan S; Bi Y; Hao M; Shang J
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34726255
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
34. miR-9-Mediated Inhibition of
Cosentino G; Romero-Cordoba S; Plantamura I; Cataldo A; Iorio MV
Cells; 2020 Sep; 9(9):. PubMed ID: 32972039
[TBL] [Abstract][Full Text] [Related]
35. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
[TBL] [Abstract][Full Text] [Related]
36. Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts.
Angelucci C; Maulucci G; Colabianchi A; Iacopino F; D'Alessio A; Maiorana A; Palmieri V; Papi M; De Spirito M; Di Leone A; Masetti R; Sica G
Br J Cancer; 2015 May; 112(10):1675-86. PubMed ID: 25880005
[TBL] [Abstract][Full Text] [Related]
37. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
39. Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.
Chang YH; Ngo NH; Vuong CK; Yamashita T; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2022 Nov; 31(21-22):659-671. PubMed ID: 35734905
[TBL] [Abstract][Full Text] [Related]
40. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
